title: Obesity and diabetes: FXR and JAK step up to BAT.
authors: Megan
authors: M
authors: Cully
mesh_terms: D002001:Adipose Tissue, Brown / Q000187:drug effects*; D000818:Animals; D001555:Benzene Derivatives / Q000494:pharmacology*; D001647:Bile Acids and Salts / Q000378:metabolism*; D005346:Fibroblast Growth Factors / Q000187:drug effects*; D007333:Insulin Resistance; D007413:Intestinal Mucosa / Q000378:metabolism*; D009765:Obesity / Q000378:metabolism*; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists*; D015430:Weight Gain / Q000187:drug effects*; D000099150:Receptor, Farnesoid X-Activated
chemical_list: D001555:Benzene Derivatives; D001647:Bile Acids and Salts; D005346:Fibroblast Growth Factors; D018160:Receptors, Cytoplasmic and Nuclear; D000099150:Receptor, Farnesoid X-Activated; C474615:fexaramine; C108526:fibroblast growth factor 15, mouse
references: Nat Cell Biol. 2015 Jan;17 (1):57-67
references: 25487280
references: Nat Med. 2015 Feb;21(2):159-65
references: 25559344